StonvexLoading…
StonvexStonvexStonvexCore line items from OGEN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2023 2023-12-31 | Q3 2023 2023-09-30 | Q2 2023 2023-06-30 | Q1 2023 2023-03-31 |
|---|---|---|---|---|
Revenue | $37.65K | $37.65K | $30.19K | $17.02K |
Operating Income | $-20.90M | $-8.11M | $-6.01M | $-2.90M |
Net Income | $-20.66M | $-7.91M | $-3.05M | $-2.84M |
EPS (Diluted) | $-9.18 | $-3.70 | $-3.04 | $-1.41 |
Total Assets | $4.97M | $7.90M | $8.46M | $12.13M |
Total Liabilities | $1.80M | Not available | Not available | Not available |
Cash & Equivalents | $3.48M | $5.77M | $6.47M | $9.16M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 3.08M | 2.57M | 2.02M | 2.02M |